Ratings Iguatemi S.A.

Equities

IGTI3

BRIGTIACNOR8

Market Closed - Sao Paulo 04:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
2.87 BRL -4.01% Intraday chart for Iguatemi S.A. -3.04% -4.33%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • The company's enterprise value to sales, at 4.09 times its current sales, is high.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Real Estate Development & Operations

1st Jan change Capi. Investor Rating ESG Refinitiv
-4.33% 1.19B
D-
+5.69% 10.99B
B-
+42.31% 6.91B
B
+21.56% 3.27B
A-
+5.87% 2.79B
D-
-19.39% 2.59B
B-
+4.77% 2.68B
B+
-5.45% 2.7B
D
-7.87% 2.5B
C+
-20.38% 2.27B -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes